BRIEF SUMMARY Vision loss and advanced eye diseases in Kosovo are reflected as a permanent burden in official data through regular compensation payments in the state's social welfare programs. According to Kosovo Agency of Statistics (ASK) data, approximately 1,800 to 2,000 individuals receive "Visually Impaired Compensation" from the state each month. The need to prevent treatable diseases such as age-related cataracts, diabetic retinopathy, and glaucoma from progressing to permanent vision loss presents an enormous B2C (consumer-oriented) market for high-technology private eye hospitals and ophthalmology polyclinics. Class-A eye clinics to be established in regions with dense patient pools such as Pristina, Ferizaj, and Gjilan represent a profitable investment alternative for both the local population and diaspora (health tourism).
u According to official welfare statistics, approximately 1,800 to 2,000 individuals receive social support (compensation) from the state for vision loss every month from 2020 to 2024. For example, as of January 2024, this number is 1,873 people across Kosovo. This mass, which causes permanent vision loss, is the result of cataract, uncontrolled diabetic retinopathy and advanced glaucoma cases that cannot be intervened in time. In terms of market analysis, this table; It proves the huge need in society for regular eye examinations, early diagnosis and accessible laser surgery (B2C services with out-of-pocket payment).
Our analysis as t Venture team; Eye health investments will not be limited to local patients only. Expats of Kosovo origin, avoiding the high healthcare costs in countries such as Switzerland and Germany, prefer private clinics in their home countries for refractive surgery (eye scratching / LASIK) procedures. However, before entering this market, import permits for medical devices from AKPPM and the equivalence processes of foreign ophthalmologists (specialists) before the Kosovo Ministry of Education and the Ministry of Health must be managed within a legal framework.
